Virtual Screening Derivat Osimertinib Terhalogenasi sebagai Kandidat Inhibitor EGFR Bermutasi pada Kanker Paru Tipe NSCLC
Effendi, Nurmaya (2023) Virtual Screening Derivat Osimertinib Terhalogenasi sebagai Kandidat Inhibitor EGFR Bermutasi pada Kanker Paru Tipe NSCLC. NEM - Anggota IKAPI, Pekalongan, Jawa Barat. ISBN 978-623-423-766-5
![[thumbnail of Monograf_2023_Nurmaya Effendi.pdf]](http://192.168.168.84/style/images/fileicons/text.png "Monograf_2023_Nurmaya Effendi.pdf") |
Text
Monograf_2023_Nurmaya Effendi.pdf Download (4MB) |
Official URL: http://www.penerbitnem.com/2023/05/virtual-screeni...
| Item Type: | Book |
|---|---|
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | FAKULTAS FARMASI |
| Depositing User: | Admin Admin |
| Date Deposited: | 26 May 2023 06:42 |
| Last Modified: | 26 May 2023 06:42 |
| URI: | http://192.168.168.84/id/eprint/2550 |
Actions (login required)
 |
View Item |